STATUS NUTRISI PASIEN GAGAL GINJAL KRONIS DENGAN DIABETES MELLITUS DAN NON-DIABETES MELLITUS

2016 ◽  
Vol 5 (2) ◽  
pp. 92-98
Author(s):  
Diyah Candra Anita

Background:Malnutrition is a common problem in chronic renal failure (CRF) patients with or without Diabetes Mellitus (DM). An assessment of nutritional status in CRF patients is encouraged to see the level of its severity. The general parameters for assessing nutritional status are serum albumin and hemoglobin. Objective:The objective of this research was to investigate the differences on thenutritional status of CRF patients with Diabetes Mellitus (DM) compared to those without DM at PKU Muhammadiyah Hospital Yogyakarta. Methods:This was a comparative descriptive research applying accidental sampling and was conducted for 6 months (June-November 2014). The main measuring devices were patients’ medical records and laboratory results of albumin and hemoglobin levels. Sampleof this study consisted of 30 respondents. Independent t-test was applied to analyze the differences of albumin and hemoglobin levels in both groups. Result:The test result showed that the albumin (p=0.917) and hemoglobin levels (p=0.168) of CRF patients without DM and that of CRF patients with DM were not significantly different. Conclusion:CRF patients with and without DM had low level of albumin and hemoglobin. Nurses shouldbe more careful in regulating fluidbalance to reduce pulmonary edema. Keywords:Chronic Renal Failure (CRF), diabetes mellitus(DM), albumin, hemoglobin

2019 ◽  
Vol 5 (2) ◽  
pp. 92-98
Author(s):  
Diyah Candra Anita

Background:Malnutrition is a common problem in chronic renal failure (CRF) patients with or without Diabetes Mellitus (DM). An assessment of nutritional status in CRF patients is encouraged to see the level of its severity. The general parameters for assessing nutritional status are serum albumin and hemoglobin. Objective:The objective of this research was to investigate the differences on thenutritional status of CRF patients with Diabetes Mellitus (DM) compared to those without DM at PKU Muhammadiyah Hospital Yogyakarta. Methods:This was a comparative descriptive research applying accidental sampling and was conducted for 6 months (June-November 2014). The main measuring devices were patients’ medical records and laboratory results of albumin and hemoglobin levels. Sampleof this study consisted of 30 respondents. Independent t-test was applied to analyze the differences of albumin and hemoglobin levels in both groups. Result:The test result showed that the albumin (p=0.917) and hemoglobin levels (p=0.168) of CRF patients without DM and that of CRF patients with DM were not significantly different. Conclusion:CRF patients with and without DM had low level of albumin and hemoglobin. Nurses shouldbe more careful in regulating fluidbalance to reduce pulmonary edema. Keywords: Chronic Renal Failure (CRF), diabetes mellitus(DM), albumin, hemoglobin


2018 ◽  
Vol 2 (2) ◽  
pp. 253
Author(s):  
Diyah Candra Anita

Introduction. Malnutrition is a common problem in patients with chronic renal failure (CRF) with Diabetes Mellitus and Non-Diabetes Mellitus. Assessments of nutritional status in CRF patients are required to measure some important parameters including serum albumin and hemoglobin. This study aimed to fi gure out the differences of nutritional status between CRF patients with diabetes mellitus and without diabetes mellitus in the inpatient unit of PKU Muhammadiyah Hospital Yogyakarta, by examining the levels of albumin and hemoglobin serum. Methods. This study applied cross sectional method of which measuring instruments were patients’ medical records of laboratory tests. This research used accidental sampling method involving 30 patients as samples. Result. The results of independent t-test showed that there was no signifi cant differences between the levels of albumin (p = 0.917) and hemoglobin (p = 0.168) between the group of non DM CRF patients and CRF patients with  M. Discussion. Therefore, further research should be performed by using a larger sample size as well as considering patients’ historical background of hemodialysis treatment.Keywords: Diabetes Mellitus (DM), Chronic Renal Failure (CRF), albumin, hemoglobin


2021 ◽  
Vol 53 (03) ◽  
pp. 259-264
Author(s):  
Mohammed Abed Jawad ◽  

Background: The current research is designed to investigate alterations in lipid peroxidation (malondialdehyde - MDA) and renal markers (urea and creatinine) in patients of chronic renal failure (CRF) as compared to the control group. Method: The study included 55 subjects, who were separated into two groups: control group, which included 15 healthy members with no history of systematic illness; and patients group, which included 40 patients with CRF divided into four groups “Non: CRF patients without any accompanied disease, DM: CRF patients with diabetes mellitus, HT: CRF patients with hypertension, and HT + DM: CRF patients with diabetes mellitus and hypertension”. Results: The findings reveal that there is a notable increase in serum concentration of MDA, urea, and creatinine, in patients group as compared to the control group. Conclusion: In all chronic renal failure patients with or without any accompanying disease, lipid peroxidation is present in pre- and post-haemodialysis patients as well as patients with CRF have high levels of urea and creatinine compared with healthy groups.


2021 ◽  
Vol 6 (1) ◽  
pp. 1287-1291
Author(s):  
Richard Santosa ◽  
Raflis Rustam ◽  
Vendry Rivaldy

Background: Arteriovenous fistula (AVF) is the preferred vascular access for hemodialysis (HD). Several factors can affect AVF maturity, such as diabetes. This study aims to determine the differences in the maturation of arteriovenous fistulas between diabetes mellitus and non-diabetes mellitus in patients with chronic kidney failure in Padang. Methods: This was a comparative cross-sectional study of patients with chronic kidney failure who underwent arteriovenous fistula surgery in Padang. The sampling technique in this study was consecutive sampling. The analysis was carried out using statistical analysis according to the existing data scale and using SPSS software. Results: This study involved 46 patients with chronic kidney failure who underwent arteriovenous fistula surgery in Padang, of which 23 patients with diabetes mellitus and 23 patients with non-diabetes mellitus. The diameter of the arteriovenous fistula between diabetes mellitus and non-diabetes mellitus in patients with chronic renal failure had a significant difference (p<0.05). There was no significant difference in flow, depth, and maturation of arteriovenous fistulas in patients with diabetes mellitus and non-diabetes mellitus with chronic renal failure. Conclusion: There is no difference in the maturation of arteriovenous fistula between patients with diabetes mellitus and non-diabetes mellitus


2003 ◽  
Vol 9 (6) ◽  
pp. 191-195
Author(s):  
O. D. Ostroumova ◽  
A. A. Zykova ◽  
A. M. Batutina

Diabetes mellitus and arterial hypertension are major risk factors of cardiovascular complications. Diabetic nephropathy is the most common cause of end-stage chronic renal failure in the world; next is hypertensive nephropathy. Microalbuminuria is the earliest clinical marker of renal dysfunction. The basic clinical significance of microalbuminuria is that it is an independent risk factor of both end-stage chronic renal failure and cardiovascular complications. Controlling blood pressure with antihypertensive agents in patients with diabetes mellitus ensures diminished microalbuminuria and retards the development of chronic renal failure. Angiotensin II receptor blockers and angiotensin-converting enzyme (ACE) inhibitors are essential drugs for the treatment of patients with diabetes mellitus and nephropathy. A combination of these two classes of drugs offers new prospects for nephroprotection in this group of patients.


1989 ◽  
Vol 35 (1) ◽  
pp. 93-97 ◽  
Author(s):  
F Engbaek ◽  
S E Christensen ◽  
B Jespersen

Abstract We evaluated an enzyme immunoassay (Novo BioLabs) for determination of hemoglobin A1c and measured the contribution of carbamylated hemoglobin to the hemoglobin A1c results obtained by HPLC for patients with chronic renal failure. The reference interval, determined for blood donors, was 0.035-0.050 (i.e., 3.5% to 5% of the total hemoglobin). For non-diabetic patients with chronic renal failure, on hemodialysis, the mean proportion of hemoglobin A1c was 0.038 (SD 0.0045); for umbilical cord blood it was 0.006-0.009. For diabetic patients with normal or near-normal renal function, results by enzyme immunoassay (y) and HPLC (x) correlated well (r = 0.83): y = 0.99x - 0.005. Added fetal hemoglobin or carbamylated hemoglobin did not interfere with enzyme immunoassay, but added carbamylated hemoglobin co-chromatographed with hemoglobin A1c. Measurements for patients with chronic renal failure, with or without diabetes, by enzyme immunoassay and by HPLC, were compared with measurements for patients with diabetes mellitus but no renal failure. Carbamylated hemoglobin contributed 0.019 to the hemoglobin A1c results obtained by HPLC for patients with chronic renal failure.


Sign in / Sign up

Export Citation Format

Share Document